| ¿µ¹® | manic depressive illness(MDI) | ÇÑ±Û | Á¶¿ïº´ |
|---|---|---|---|
| ¼³¸í | Á¶º´°ú ¿ì¿ïº´ÀÌ ¹ø°¥¾Æ °¡¸ç ³ªÅ¸³ª´Â Á¤½Åº´. Á¶º´Àº 3°¡ÁöÀÇ Å« Ư¡À» °¡Áö°í Àִµ¥ ±×°ÍÀº Áö³ªÄ£ Àڽۨ, Áö³ªÄ£ °ú´ÙȰµ¿, ³Ê¹«³ª °í¾çµÈ ±âºÐÀÌ ±×°ÍÀÌ´Ù. µû¶ó¼ ±×µéÀº ¾ð¶æ º¸±â¿£ Àڽۨ¿¡ Â÷¼ ¼¼»óÀ» »ì¾Æ°¡´Â °Íó·³ º¸À̳ª, ½ÇÁ¦ÀûÀ¸·Î´Â ±× ÀÏÀ» ¹úÀ̱⸸ ÇÒ »Ó, ±× ÀÏÀ» °¨´çÇÒ ´É·ÂÀº ¾ø¾î ´ë°³ »ç¾÷À» Çϸé, ÆÄ»êÇϰųª, ³²ÀÇ Àç»êÀ» ÅÁÁøÇϱ⵵ ÇÏ¸é¼ ÀÚ½ÅÀº ¿©ÀüÈ÷ Àڽۨ¼Ó¿¡¼ »ì¾Æ ´Ù¸¥ °¡Á·µé¿¡ ÀÇÇØ¼ ²ø·Á º´¿ø¿¡ ¿À°Ô µÇ´Â °æ¿ì°¡ ¸¹´Ù. ÇÑÆí ¿ïº´Àº Áö³ªÄ¡°Ô ¿ì¿ïÇÑ ±âºÐ, ÀÚ»ìÀÇ¿å, ¶§¿¡ µû¶ó¼´Â Áö³ªÄ£ ÃÊÁ¶°¨, Àλý¿¡ÀÇ Áö³ªÄ£ Ç㹫°¨ µîÀ» Áõ»óÀ¸·Î ÇÏ¿© ÁÖÀ§¿¡¼ÀÇ ¾Æ¹«¸® ¸¹Àº Ãæ°íµµ ±Í¿¡ µé¾î¿ÀÁö ¾Ê´Â´Ù. ´ë°³ È¥ÀÚ ³õ¾ÆµÎ°Ô µÇ¸é, ²À ÀÚ»ì½Ãµµ¸¦ ÇÏ°Ô µÇ¸ç, ƯÈ÷ °»³â±â ¿ì¿ïÁõ¿¡¼´Â ÀÚ»ìÀÇ ºóµµ°¡ ³ô¾Æ ÀÔ¿øÄ¡·á¸¦ ¿äÇÑ´Ù. |
||
| ¿µ¹® | anxiety | ÇÑ±Û | ºÒ¾È |
|---|---|---|---|
| ¼³¸í | ½ÇÁ¦·Î Á¸ÀçÇÏÁö ¾Ê´Â À§Çè¿¡ ´ëÇØ¼ ´À³¢´Â ºÒÀ¯ÄèÇÑ ½É¸®»óÅÂ. ´ë°³ ÇÇ·Î, °¡½¿ÀÌ ¶Ù´Â µîÀÇ ½ÅüÀû ¹ÝÀÀÀ» µ¿¹ÝÇÑ´Ù. Á¸ÀçÇÏÁö ¾Ê´Â À§ÇèÀº ÀÚ½ÅÀÇ »ó»óÀ̳ª ³»ºÎÀû °¥µî¿¡ ÀÇÇØ¼ »ý°Ü³´Ù. |
||
| ¿µ¹® | anxiety neurosis | ÇÑ±Û | ºÒ¾È½Å°æÁõ |
|---|---|---|---|
| ¼³¸í | Á¤½Å°úÀû ÁúȯÀº ´ë°³ ½Å°æÁõ(neurosis)¿Í Á¤½Åº´(psychosis)ÀÇ µÎ °¡Áö·Î ³ª´«´Ù. À§ÀÇ µÎ °¡Áö ¸ðµÎ°¡ Á¤½ÅÀÌ Á¤»ó»ç¶÷°ú ´Ù¸¥ °ÍÀº ¶È °°Áö¸¸ ½Å°æÁõ°ú Á¤½Åº´ÀÇ Â÷ÀÌÁ¡Àº Çö½Ç¿¡ ´ëÇÑ ÀνÄÀÇ Â÷ÀÌÀÌ´Ù. Áï Çö½ÇÀ» Á¤È®È÷ ÀÎÁöÇϰí Çö½Ç¿¡ ´ëÇÑ Á¤È®ÇÑ ÆÇ´ÜÀ» ÇÒ ¼ö ÀÖ´Â °æ¿ì¸¦ ½Å°æÁõÀ̶ó ÇÏ°í ±×·¸Áö ¾ÊÀ» °æ¿ì¿¡´Â Á¤½Åº´À̶ó°í ÇÑ´Ù. ½Å°æÁõÀÇ °æ¿ì´Â Á¤»óÀ̶ó°í »ý°¢µÇ´Â »ç¶÷µµ ¸¹ÀÌ °¡Áö°í ÀÖ´Â Á¤½Å°úÀû ÁúȯÀÌ°í ´ë°³ Áõ»óÀÌ ¾çÈ£ÇÏ°í ¿¹Èİ¡ ÁÁ´Ù. ºÒ¾È ½Å°æÁõÀ̶õ ºÒ¾ÈÀ» ÁÖ Áõ»óÀ¸·Î ÇÏ´Â ½Å°æÁõÀ» ¸»ÇÑ´Ù. |
||
| ¿µ¹® | anxiety disorder | ÇÑ±Û | ºÒ¾ÈÀå¾Ö |
|---|---|---|---|
| ¼³¸í | ½É¸®Àû ºÒ¾ÈÁ¤À̳ª ºÒ¾È µîÀ» ÁÖ Æ¯Â¡À¸·Î ÇÏ´Â Á¤½Å°úÀû º´ÅÂ. ´ëÇ¥ÀûÀÎ ¿¹·Î´Â °øÆ÷Áõ(phobia)¿Í °øÈ²Àå¾Ö(panic disorder), Àü¹ÝÀû ºÒ¾ÈÀå¾Ö(generalized anxiety disorder) µîÀÌ ÀÖ´Ù. °øÆ÷ÁõÀ̶õ ƯÁ¤ÇÑ Àå¼Ò³ª »óȲ¿¡ ´ëÇØ¼ º´ÀûÀÎ ºÒ¾ÈÀ» ´À³¢´Â °ÍÀ¸·Î ±¤Àå°øÆ÷Áõ(agoraphobia): Ź Æ®ÀÎ °ø°£À» ¹«¼¿öÇÔ. »çȸ°øÆ÷Ãþ(social phobia): ´Ù¸¥ »ç¶÷¾Õ¿¡ ¼´Â °ÍÀ» ¹«¼¿ö ÇÔ. °í¼Ò°øÆ÷Ãþ(acrophobia): ³ôÀº °÷¿¡ °¡´Â °ÍÀ» ¹«¼¿öÇÔ. ÁøÆó°øÆ÷Áõ(claustrophobia): ¹ÐÆóµÈ °ø°£À» ¹«¼¿öÇÔ. µ¿¹°°øÆ÷Áõ(zoophobia): µ¿¹°À» º´ÀûÀ¸·Î ¹«¼¿öÇÔ µîÀ» Æ÷ÇÔÇÑ´Ù. °øÈ²Àå¾Ö(panic disorde)¶õ ¿ÜºÎÀÇ À§ÇèÇÑ ÀÚ±ØÀÌ ¾ø´Âµ¥µµ ºÒ±¸ÇÏ°í °©Àڱ⠱ؽÉÇÑ °øÆ÷¸¦ ´À³¢´Â °ÍÀ» ¸»ÇÑ´Ù. ´ë°³ ½ÉÀåÀÌ ½ÉÇÏ°Ô ¶Ù°Å³ª ½ÄÀº ¶¡À» È긮°í, ½Ç½Å, È£Èí°ï¶õ µîÀÇ Áõ»óÀ» µ¿¹ÝÇÑ´Ù. Àü¹ÝÀû ºÒ¾ÈÀå¾Ö(generalized anxiety disorder)¶õ 1°³¿ùÀÌ»ó Áö¼ÓÀûÀÎ ºÒ¾ÈÀ» ´À³¢´Â °ÍÀ» ¸»ÇÑ´Ù. ´ë°³ »ç¼ÒÇÑ ÀÏ»óÀÇ ÀÏ¿¡ ´ëÇÑ ºÒ¾ÈÀ» ´À³¢¸ç, ºÒ¾ÈÀÇ ´ë»óÀÌ ¾ø´Â °æ¿ì¿¡´Â ¾ðÁ¦ ºÒ¾ÈÀ» ´À³¥Áö ¸ð¸¥´Ù´Â ºÒ¾È°¨(¿¹±âºÒ¾È)À» È£¼ÒÇÑ´Ù. ´ë°³ ¼è¾à, ¾îÁö·¯¿ò, ¼Õ¶³¸², ¶¡À» È긮´Â µîÀÇ ½ÅüÀû Áõ»óÀ» µ¿¹ÝÇÑ´Ù. |
||
| ASI | addiction severity index; anxiety state inventory; anxiety status inventory; arthroscopic screw inst... |
|---|---|
| MDI | Manic(Mood) Depressive Illness Metered-dose inhaler |
| IDS | iduronate sulfatase; immune deficiency state; inhibitor of DNA synthesis; integrated delivery system... |
| IDS-SR | Inventory for Depressive Symptomatology-Systems Review |
| MD | Doctor of Medicine [Lat. Medicinae Doctor]; magnesium deficiency; main duct; maintenance dose; major... |
| M.D.D. | Major Depressive Disorder |
|---|---|
| MDE | Major Depressive Episode |
| MDI | Manic depressive illness |
| ASI | Anxiety Sensitivity Index |
| AS | Anxiety sensitivity |
| manic-depressive | 1. Pertaining to a manic-depressive psychosis (bipolar disorder). 2. One suffering from such a disorder. (05 Mar 2000) |
|---|---|
| manic-depressive disease | See manic-depression. (12 Dec 1998) |
| manic-depressive disorder | An obsolete term for one of the mood disorders; i.e., bipolar disorder, depression; affective psychosis, affective disorder, bipolar disorder, and endogenous depression. (05 Mar 2000) |
| manic-depressive illness | Now referred to as bipolar illness, characterised by the occurrence of mania (euphoria) alternating with bouts of depression. (27 Sep 1997) |
| manic-depressive psychosis | Perviously referred to as manic depressive illness, characterised by the occurrence of mania (euphoria) alternating with bouts of depression. (27 Sep 1997) |
| depressive | 1. Pushing down. 2. Pertaining to or causing depression. (05 Mar 2000) |
| depressive disorder | An affective disorder manifested by either a dysphoric mood or loss of interest or pleasure in usual activities. The mood disturbance is prominent and relatively persistent. (12 Dec 1998) |
| depressive neurosis | See: depression, dysthymia. (05 Mar 2000) |
| depressive psychosis | A major disorder of mood in which biologic factors are believed to play a prominent role. See: depression. (05 Mar 2000) |
| depressive reaction | 1. A lowering or decrease of functional activity. 2. <psychiatry> A mental state of depressed mood characterised by feelings of sadness, despair and discouragement. Depression ranges from normal feelings of the blues through dysthymia to major depression. It in many ways resembles the grief and mourning that follow bereavement, there are often feelings of low self esteem, guilt and self reproach, withdrawal from interpersonal contact and somatic symptoms such as eating and sleep disturbances. Origin: L. Depremere = to press down (18 Nov 1997) |
| depressive stupor | A stuporous syndrome from which recovery is the rule, as opposed to malignant stupor. Synonym: depressive stupor. (05 Mar 2000) |
| depressive syndrome | 1. A lowering or decrease of functional activity. 2. <psychiatry> A mental state of depressed mood characterised by feelings of sadness, despair and discouragement. Depression ranges from normal feelings of the blues through dysthymia to major depression. It in many ways resembles the grief and mourning that follow bereavement, there are often feelings of low self esteem, guilt and self reproach, withdrawal from interpersonal contact and somatic symptoms such as eating and sleep disturbances. Origin: L. Depremere = to press down (18 Nov 1997) |
| disease, manic-depressive | See Manic-depression. (12 Dec 1998) |
| anti-anxiety agents | Agents that alleviate anxiety, tension, and neurotic symptoms, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions. Some are also effective as anticonvulsants, muscle relaxants, or anaesthesia adjuvants. Adrenergic beta-antagonists are commonly used in the symptomatic treatment of anxiety but are not included here. Substances with a benzodiazepine ring structure widely used to treat anxiety and neuroses. Drugs in this class also generally have sedative or weak hypnotic properties and may be effective as muscle relaxants, anticonvulsants, and anaesthesia adjuvants. (12 Dec 1998) |
| anxiety | <psychology> The unpleasant emotional state consisting of psychophysiological responses to anticipation of unreal or imagined danger, ostensibly resulting from unrecognised intrapsychic conflict. Physiological concomitants include increased heart rate, altered respiration rate, sweating, trembling, weakness and fatigue, psychological concomitants include feelings of impending danger, powerlessness, apprehension and tension. (18 Nov 1997) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|